# Moderate-to-Severe Dry Eye Disease Relief Using Acoltremon

> **NCT07268599** · — · ENROLLING_BY_INVITATION · sponsor: **Colvard Kandavel Eye Center** · enrollment: 50 (estimated)

## Conditions studied

- Dry Eye Disease (DED)

## Interventions

- **DRUG:** Acoltremon

## Key facts

- **NCT ID:** NCT07268599
- **Lead sponsor:** Colvard Kandavel Eye Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-11-24
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07268599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07268599, "Moderate-to-Severe Dry Eye Disease Relief Using Acoltremon". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07268599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*